Page last updated: 2024-08-16

pyrimethamine and ethambutol

pyrimethamine has been researched along with ethambutol in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (15.38)29.6817
2010's11 (84.62)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Ali, MA; Choon, TS; Ismail, R; Kumar, RS; Wei, AC; Yoon, YK1
Danac, R; Mangalagiu, II1
Asís, SE; Buldain, GY; Muscia, GC1
Ali, MA; Choon, TS; Kanchithalaivan, S; Ponnuchamy, S; Ranjith Kumar, R1
Ashraf Ali, M; Choon, TS; Devi Bala, B; Muthusaravanan, S; Perumal, S1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Moreno-Viguri, E; Pérez-Silanes, S; Santivañez-Veliz, M; Torres, E1
Ashraf Ali, M; Bharkavi, C; Muthusubramanian, S; Osman, H; Perumal, S; Vivek Kumar, S2
Baikova, IP; Giniyatullina, GV; Kataev, VE; Kazakova, OB; Lopatina, TV; Medvedeva, NI; Smirnova, IE1
Bera, S; Mondal, D1
Asencio Marchante, R; Lissen Otero, E1

Reviews

2 review(s) available for pyrimethamine and ethambutol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Insights of synthetic analogues of anti-leprosy agents.
    Bioorganic & medicinal chemistry, 2019, 07-01, Volume: 27, Issue:13

    Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship

2019

Other Studies

11 other study(ies) available for pyrimethamine and ethambutol

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
A facile three-component [3+2]-cycloaddition for the regioselective synthesis of highly functionalised dispiropyrrolidines acting as antimycobacterial agents.
    Bioorganic & medicinal chemistry letters, 2013, Mar-01, Volume: 23, Issue:5

    Topics: Anti-Bacterial Agents; Cycloaddition Reaction; High-Throughput Screening Assays; Microbial Sensitivity Tests; Pyrrolidines

2013
Antimycobacterial activity of nitrogen heterocycles derivatives: bipyridine derivatives. Part III.
    European journal of medicinal chemistry, 2014, Mar-03, Volume: 74

    Topics: Antitubercular Agents; Heterocyclic Compounds; Magnetic Resonance Spectroscopy; Models, Molecular; Nitrogen; Pyridines

2014
Design, synthesis and evaluation of acridine and fused-quinoline derivatives as potential anti-tuberculosis agents.
    European journal of medicinal chemistry, 2014, Feb-12, Volume: 73

    Topics: Acridines; Animals; Antitubercular Agents; Cell Line; Cyclization; Drug Design; Drug Evaluation, Preclinical; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quinolines

2014
Antimycobacterial evaluation of novel hybrid arylidene thiazolidine-2,4-diones.
    Bioorganic & medicinal chemistry letters, 2014, Feb-15, Volume: 24, Issue:4

    Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazolidinediones

2014
Sequential synthesis of amino-1,4-naphthoquinone-appended triazoles and triazole-chromene hybrids and their antimycobacterial evaluation.
    European journal of medicinal chemistry, 2014, Oct-06, Volume: 85

    Topics: Antitubercular Agents; Benzopyrans; Chemistry Techniques, Synthetic; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Naphthoquinones; Triazoles

2014
Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis.
    Bioorganic & medicinal chemistry letters, 2016, May-01, Volume: 26, Issue:9

    Topics: Animals; Antitubercular Agents; Cell Line; Cyclic N-Oxides; Drug Resistance, Multiple, Bacterial; Latent Tuberculosis; Mice; Mycobacterium tuberculosis; Quinoxalines; Tuberculosis, Multidrug-Resistant

2016
A facile stereoselective synthesis of dispiro-indeno pyrrolidine/pyrrolothiazole-thiochroman hybrids and evaluation of their antimycobacterial, anticancer and AchE inhibitory activities.
    Bioorganic & medicinal chemistry, 2016, 11-15, Volume: 24, Issue:22

    Topics: Acetylcholinesterase; Anti-Bacterial Agents; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholinesterase Inhibitors; Chromones; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Indenes; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Spiro Compounds; Stereoisomerism; Structure-Activity Relationship; Thiazoles

2016
One-pot microwave assisted stereoselective synthesis of novel dihydro-2'H-spiro[indene-2,1'-pyrrolo-[3,4-c]pyrrole]-tetraones and evaluation of their antimycobacterial activity and inhibition of AChE.
    Bioorganic & medicinal chemistry letters, 2017, 07-15, Volume: 27, Issue:14

    Topics: Acetylcholinesterase; Antitubercular Agents; Cholinesterase Inhibitors; Crystallography, X-Ray; Drug Design; Enzyme Activation; Inhibitory Concentration 50; Microbial Sensitivity Tests; Microwaves; Molecular Conformation; Mycobacterium tuberculosis; Pyrroles; Stereoisomerism; Structure-Activity Relationship

2017
Synthesis and antimycobacterial activity of triterpeni≿ A-ring azepanes.
    European journal of medicinal chemistry, 2018, Jan-01, Volume: 143

    Topics: Antitubercular Agents; Azepines; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triterpenes

2018
[Secondary prevention of opportunistic infections in HIV-infected patients].
    Revista clinica espanola, 2001, Volume: 201, Issue:2

    Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antiprotozoal Agents; Antitubercular Agents; Antiviral Agents; Clarithromycin; Cytomegalovirus Infections; Drug Therapy, Combination; Ethambutol; Ganciclovir; Humans; Leucovorin; Mycobacterium avium-intracellulare Infection; Pneumonia, Pneumocystis; Pyrimethamine; Recurrence; Rifabutin; Sulfadiazine; Sulfamethoxazole; Toxoplasmosis; Trimethoprim

2001